AngioDynamics, Inc. (ANGO)

$23.51

-0.11 (-0.47%)
Rating:
Recommendation:
Buy
Symbol ANGO
Price $23.51
Beta 0.900
Volume Avg. 0.23M
Market Cap 916.187M
Shares () -
52 Week Range 17.56-32.0
1y Target Est -
DCF Unlevered ANGO DCF ->
DCF Levered ANGO LDCF ->
ROE -6.16% Neutral
ROA -4.80% Neutral
Operating Margin -
Debt / Equity 30.22% Neutral
P/E -
P/B 2.17 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest ANGO news


Mr. James Clemmer
Healthcare
Medical Instruments & Supplies
NASDAQ Global Select

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.